Listed by the USPTO as STEINKE, SEAN JAMES
Tech Center 1700 • Art Units: 1613 1619 1655 1731
This examiner grants 12% of resolved cases
Sean James Steinke works in Art Unit 1613 of Tech Center 1700, where he has resolved 16 cases. The examiner has an allowance rate of 12.5% and a median days to allowance of 1200. These metrics indicate a difficult environment for applicants.
The interview lift is 42.9%, which is a critical data point given the 12.5% base allowance rate. This suggests that interviews are an effective way to secure a grant. Top companies include BASF SE, L'Oréal, and ADAMA Agricultural Solutions Ltd.
Firms such as BakerHostetler and Foley & Lardner LLP are active here. Practitioners should consider interviews to overcome the 12.5% allowance rate and 1200-day median pendency across the 16 resolved cases.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18721830 | ACOUSTICALLY-RESPONSIVE BIOINKS FOR EXTRUSION-BASED 3D-BIOPRINTING | Non-Final OA | The Regents of the University of Michigan |
| 18684083 | POLYMERS AND NANOPARTICLES FOR INTRAMUSCULAR NUCLEIC ACID DELIVERY | Non-Final OA | The Johns Hopkins University |
| 18577406 | Herbicidal Compositions | Final Rejection | SYNGENTA CROP PROTECTION AG |
| 18720082 | A COMPOSITION COMPRISING POLYMERS | Non-Final OA | BASF SE |
| 18553452 | ADDITIVES FOR ENHANCING THE PESTICIDAL EFFECTIVENESS OF PESTICIDAL MICROORGANISMS | Non-Final OA | BASF SE |
| 17754214 | Stable Aqueous Compositions of Fertilizer and Agriculturally Active Compound | Final Rejection | BASF SE |
| 17797652 | METHOD FOR INCREASING EICOSAPENTAENOIC ACID LEVEL IN THE PLASMA OF AN ANIMAL | Final Rejection | DSM IP Assets B.V. |
| 18018220 | ARTIFICIAL PLACENTA VACCINE FOR ORGAN TRANSPLANTATION | Final Rejection | Arizona Board of Regents on Behalf of Arizona State University |
| 17625955 | METHOD FOR LOADING OF MICROORGANISMS ON MULTIPHASE BIOMATERIALS | Non-Final OA | Evonik Operations GmbH |
| 18069796 | ENCAPSULATION OF BIOACTIVE INGREDIENTS BY MULTIPLEX EMULSION | Final Rejection | The Board of Regents of the University of Texas System |
| 18115215 | CELLULOSE ACETATE PARTICLES, COSMETIC COMPOSITION, AND METHOD FOR PRODUCING CELLULOSE ACETATE PARTICLES | Non-Final OA | Daicel Corporation |
| 17677676 | TOPICAL NEUROSTEROID FORMULATIONS | Final Rejection | Arizona Board of Regents on Behalf of the University of Arizona |
| 18706694 | POLYHYDROXYALKANOATE COPOLYMER BEARING AN ACETOACETATE GROUP, COMPOSITION CONTAINING SAME AND COSMETIC USE THEREOF | Non-Final OA | L'OREAL |
| 18518827 | COMPOSITIONS AND METHODS FOR TREATING KERATIN SUBSTRATES | Non-Final OA | L'Oreal |
| 18554855 | SOLID ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS | Final Rejection | L'OREAL |
| 18264536 | Design and Production of Customizable and Highly Aligned Fibrillar Collagen Scaffolds | Final Rejection | Northeastern University |
| 18556728 | AQUEOUS DISPERSION | Final Rejection | DIC Corporation |
| 18702032 | NOVEL 2,2'-(OCTYLIMINO)BIS[ETHANOL] COMPOSITIONS AND USES THEREOF | Non-Final OA | INTERNATIONAL FLAVORS & FRAGRANCES INC. |
| 17909693 | COSMETIC OR PHARMACEUTICAL USE OF AVENANTHRAMIDE L | Final Rejection | SYMRISE AG |
| 17803774 | Formulated and/or Co-Formulated Liposome Compositions Containing Immunogenic Cell Death (ICD) Inducing Prodrugs Useful In The Treatment of Cancer and Methods Thereof | Non-Final OA | Nammi Therapeutics, Inc. |
| 18736095 | ORAL PEPTIDE DRUG STRUCTURE AND MANUFACTURING METHOD THEREOF | Non-Final OA | Merdury Biopharmaceutical Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy12.5% of resolved applications examined by Sean James Steinke were allowed (16 resolved cases), compared with 34.0% across Art Unit 1613 over the last five years.
This examiner's interview lift is +42.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Sean James Steinke took 1,200 days on average from filing to allowance.
Sean James Steinke examines applications in Art Unit 1613 in Tech Center 1700 (Chemistry & Materials).
